You have 9 free searches left this month | for more free features.

DDRiver

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center
May 22, 2023

Other Cancer Trial in Budapest ([14C]M6620, M6620, Topotecan)

Recruiting
  • Other Cancer
  • Budapest, Hungary
  • +1 more
Jun 22, 2022

Advanced Solid Tumors Trial in Houston, San Antonio, Toronto (M4076)

Recruiting
  • Advanced Solid Tumors
  • Houston, Texas
  • +2 more
Jul 13, 2022

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)

Active, not recruiting
  • Small-cell Lung Cancer
  • Santa Rosa, California
  • +47 more
Jun 24, 2022

Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)

Completed
  • Locally Advanced Rectal Cancer
  • Peposertib 50 mg
  • +5 more
  • Aurora, Colorado
  • +13 more
Jun 9, 2022